Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jun-24 5:57 PM View:  | Myriad Genetics Inc. (MYGN) | 04-Jun-24 | Market Sale (Planned) | 3,788 | $22.05 | $83,525.40 | (10%) 36.7K to 32.92K | (17%) |
| 04-Jun-24 5:57 PM View: | Myriad Genetics Inc. (MYGN) | 03-Jun-24 | Market Sale (Planned) | 3,788 | $22.04 | $83,487.50 | (9%) 40.49K to 36.7K | (17%) |
| 02-Jun-23 6:15 PM View: | Myriad Genetics Inc. (MYGN) | 02-Jun-23 | Sale (Planned) | 8,638 | $23.01 | $198,760.00 | (18%) 49.13K to 40.49K | |
| 02-Jun-23 6:15 PM View: | Myriad Genetics Inc. (MYGN) | 01-Jun-23 | Grant | 15,151 | -- | -- | 45% 33.98K to 49.13K | |
| 06-Jun-22 7:20 PM View: | Myriad Genetics Inc. (MYGN) | 06-Jun-22 | Sale (Planned) | 6,424 | $19.25 | $123,673.00 | (16%) 40.4K to 33.98K | |
| 03-Jun-22 5:27 PM View: | Myriad Genetics Inc. (MYGN) | 02-Jun-22 | Grant | 17,275 | -- | -- | 75% 23.13K to 40.4K | |
| 17-Jun-21 5:41 PM View: | Myriad Genetics Inc. (MYGN) | 17-Jun-21 | Market Sale (Planned) | 3,139 | $30.52 | $95,794.70 | (12%) 26.27K to 23.13K | 1% |
| 04-Jun-21 7:11 PM View: | Myriad Genetics Inc. (MYGN) | 03-Jun-21 | Grant | 12,848 | -- | -- | 96% 13.42K to 26.27K | |
| 01-Jun-21 7:15 PM View: | Myriad Genetics Inc. (MYGN) | 28-May-21 | Market Sale (Planned) | 7,142 | $28.99 | $207,023.00 | (35%) 20.56K to 13.42K | 1% |
| 28-May-21 6:48 PM View: | Myriad Genetics Inc. (MYGN) | 27-May-21 | Disposition | 15,889 | -- | -- | (44%) 36.45K to 20.56K | |
| 07-Dec-20 5:27 PM View: | Myriad Genetics Inc. (MYGN) | 04-Dec-20 | Grant | 15,889 | -- | -- | 77% 20.56K to 36.45K | |
| 28-May-20 11:17 AM View: | Myriad Genetics Inc. (MYGN) | 27-May-20 | Grant | 20,562 | -- | -- | 100% 0 to 20.56K | |
| 07-Jun-19 6:51 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 30-Apr-19 | Grant | 176 | $68.78 | $12,105.60 | < 1% 47.51K to 47.69K | |
| 03-Apr-19 1:17 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 01-Apr-19 | Market Sale | 13,473 | $89.00 | $1,199,100.00 | (22%) 60.98K to 47.51K | (3%) |
| 29-Mar-19 6:19 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 27-Mar-19 | Market Sale | 100 | $90.00 | $9,000.00 | (< 1%) 61.08K to 60.98K | 2% |
| 26-Mar-19 8:30 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 22-Mar-19 | Payment of Exercise | 3,598 | $88.05 | $316,804.00 | (6%) 64.68K to 61.08K | (< 1%) |
| 19-Mar-19 8:43 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-Mar-19 | Grant | 9,370 | -- | -- | 15% 62.54K to 71.91K | |
| 19-Mar-19 8:43 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-Mar-19 | Payment of Exercise | 7,227 | $94.53 | $683,168.00 | (10%) 71.91K to 64.68K | |
| 05-Mar-19 8:08 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 01-Mar-19 | Grant | 12,205 | -- | -- | 24% 51.24K to 63.45K | |
| 05-Mar-19 8:08 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 01-Mar-19 | Payment of Exercise | 912 | $94.76 | $86,421.10 | (1%) 63.45K to 62.54K | |
| 20-Dec-18 6:06 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 31-Oct-18 | Grant | 175 | $68.78 | $12,036.80 | < 1% 51.07K to 51.24K | |
| 26-Jun-18 8:31 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 22-Jun-18 | Market Sale | 10,000 | $99.00 | $990,005.00 | (16%) 61.07K to 51.07K | 5% |
| 06-Jun-18 8:15 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 04-Jun-18 | Payment of Exercise | 1,711 | $92.07 | $157,532.00 | (3%) 62.78K to 61.07K | (2%) |
| 06-Jun-18 8:15 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 30-Apr-18 | Grant | 167 | $68.78 | $11,486.60 | < 1% 62.61K to 62.78K | |
| 25-Apr-18 8:37 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 23-Apr-18 | Market Sale | 11,059 | $82.15 | $908,497.00 | (15%) 73.6K to 62.54K | (14%) |
| 26-Mar-18 8:08 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 22-Mar-18 | Payment of Exercise | 3,583 | $81.36 | $291,513.00 | (5%) 77.19K to 73.6K | (16%) |
| 19-Mar-18 9:45 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-Mar-18 | Grant | 12,480 | -- | -- | 18% 68.52K to 81.0K | |
| 19-Mar-18 9:45 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-Mar-18 | Payment of Exercise | 3,815 | $83.57 | $318,820.00 | (5%) 81.0K to 77.19K | (12%) |
| 13-Mar-18 6:07 PM View: | Oncothyreon Inc (CASC) | 09-Mar-18 | Disposition (change in control) | 21,006 | -- | -- | (100%) 21.01K to 0 | |
| 06-Mar-18 8:48 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 02-Mar-18 | Payment of Exercise | 1,609 | $79.86 | $128,495.00 | (2%) 70.13K to 68.52K | (18%) |
| 28-Feb-18 8:57 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 26-Feb-18 | Grant | 12,529 | -- | -- | 22% 57.6K to 70.13K | |
| 14-Feb-18 10:00 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 31-Oct-17 | Grant | 162 | $69.78 | $11,303.90 | < 1% 57.44K to 57.6K | |
| 26-Sep-17 5:22 PM View: | Oncothyreon Inc (CASC) | 24-Sep-17 | Payment of Exercise | 594 | $3.94 | $2,340.36 | (3%) 21.6K to 21.01K | (156%) |
| 26-Sep-17 5:22 PM View: | Oncothyreon Inc (CASC) | 24-Sep-17 | Option Exercise | 2,375 | -- | -- | 12% 19.23K to 21.6K | |
| 27-Jun-17 5:41 PM View: | Oncothyreon Inc (CASC) | 24-Jun-17 | Payment of Exercise | 2,265 | $3.78 | $8,561.70 | (11%) 21.49K to 19.23K | (167%) |
| 27-Jun-17 5:41 PM View: | Oncothyreon Inc (CASC) | 24-Jun-17 | Option Exercise | 9,058 | -- | -- | 73% 12.43K to 21.49K | |
| 13-Jun-17 4:42 PM View: | Oncothyreon Inc (CASC) | 12-Jun-17 | Payment of Exercise | 537 | $3.34 | $1,793.58 | (4%) 12.97K to 12.43K | (202%) |
| 13-Jun-17 4:42 PM View: | Oncothyreon Inc (CASC) | 12-Jun-17 | Option Exercise | 2,148 | -- | -- | 20% 10.82K to 12.97K | |
| 06-Jun-17 9:07 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 02-Jun-17 | Payment of Exercise | 1,801 | $90.72 | $163,387.00 | (7%) 25.1K to 23.3K | (4%) |
| 17-May-17 6:50 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-May-17 | Payment of Exercise | 1,722 | $91.50 | $157,563.00 | (6%) 26.83K to 25.1K | (3%) |
| 17-May-17 6:50 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 28-Apr-17 | Grant | 155 | $70.30 | $10,897.10 | < 1% 26.67K to 26.83K | |
| 24-Mar-17 6:41 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 22-Mar-17 | Grant | 12,200 | -- | -- | 84% 14.47K to 26.67K | |
| 17-Mar-17 6:30 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 16-Mar-17 | Market Sale | 1,989 | $91.96 | $182,908.00 | (12%) 16.46K to 14.47K | (2%) |
| 17-Mar-17 6:30 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 15-Mar-17 | Payment of Exercise | 4,301 | $92.50 | $397,842.00 | (21%) 20.76K to 16.46K | (2%) |
| 08-Mar-17 7:28 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 06-Mar-17 | Market Sale | 2,303 | $93.32 | $214,916.00 | (10%) 23.06K to 20.76K | (< 1%) |
| 07-Mar-17 6:38 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 03-Mar-17 | Payment of Exercise | 2,283 | $93.95 | $214,488.00 | (9%) 25.35K to 23.06K | (< 1%) |
| 02-Mar-17 6:20 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 01-Mar-17 | Market Sale | 5,000 | $94.50 | $472,500.00 | (16%) 30.35K to 25.35K | < 1% |
| 02-Mar-17 6:20 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 28-Feb-17 | Option Exercise | 30,000 | $63.10 | $1,893,000.00 | 99% 30.35K to 60.35K | |
| 02-Mar-17 6:20 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 28-Feb-17 | Market Option Sale | 30,000 | $94.00 | $2,820,000.00 | (50%) 60.35K to 30.35K | < 1% |
| 28-Feb-17 10:00 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 24-Feb-17 | Grant | 12,247 | -- | -- | 68% 18.1K to 30.35K |